leiodermatolide: an antimitotic agent isolated from the marine sponge Leiodermatium; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 71528796 |
| CHEMBL ID | 4083537 |
| MeSH ID | M0558903 |
| Synonym |
|---|
| leiodermatolide |
| Q44316165 |
| CHEMBL4083537 |
| 1006046-07-6 |
| DTXSID201043920 |
Leiodermatolide is an antimitotic macrolide isolated from the marine sponge.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Leiodermatolide is an antimitotic macrolide isolated from the marine sponge Leiodermatium sp. " | ( Total synthesis of the antimitotic marine macrolide (-)-leiodermatolide. Dalby, SM; Millican, DC; Ng, KK; Paterson, I; Williams, S, 2014) | 2.09 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1478487 | Cytotoxicity against human Aspc-1 cells incubated for 72 hrs by MTT assay | 2017 | Journal of natural products, 03-24, Volume: 80, Issue:3 | Analogues of the Potent Antitumor Compound Leiodermatolide from a Deep-Water Sponge of the Genus Leiodermatium. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||